Article

Community-Based Argentine Tango Dance Program Is Associated With Increased Activity Participation Among Individuals With Parkinson's Disease

Program in Occupational Therapy, Washington University School of Medicine
Archives of physical medicine and rehabilitation (Impact Factor: 2.18). 08/2012; 94(2). DOI: 10.1016/j.apmr.2012.07.028
Source: PubMed

ABSTRACT OBJECTIVE: To determine the effect of a 12-month community-based tango dance program on activity participation among individuals with Parkinson disease (PD). DESIGN: Randomized controlled trial with assessment at baseline, 3, 6, and 12 months. SETTING: The intervention was administered in the community; assessments were completed in a university laboratory. PARTICIPANTS: Sixty-two volunteers with PD enrolled in the study and were randomized to treatment group. Ten participants did not receive the allocated intervention, so the final analyzed sample included 52 participants. INTERVENTION: Participants were randomly assigned to the Tango group, which involved 12 months of twice weekly Argentine tango dance classes, or to the no intervention Control group (n = 26 per group). MAIN OUTCOME MEASURES: Current, new and retained participation in instrumental, leisure and social activities as measured by the Activity Card Sort (with the "dance" activity removed). RESULTS: Total Current participation in the Tango group was higher at 3, 6, and 12 months compared to baseline (ps ≤ 0.008), while the Control group did not change (ps ≥ 0.11). Total Activity Retention (since onset of PD) in the Tango group increased from 77% to 90% (p = 0.006) over the course of the study, whereas the Control group remained around 80% (p = 0.60). These patterns were similar in the separate activity domains. The Tango group gained a significant number of New Social activities (p = 0.003), but the Control group did not (p = 0.71). CONCLUSIONS: Individuals with PD who participated in a community-based Argentine tango class reported increased participation in complex daily activities, recovery of activities lost since the onset of PD, and engagement in new activities. Incorporating dance into the clinical management of PD may benefit participation and subsequently quality of life for this population.

1 Bookmark
 · 
178 Views
  • Alternative and Complementary Therapies 10/2013; 19(5):265-269. DOI:10.1089/act.2013.19502
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of Parkinson's disease (PD) appears to be lower in Asia compared to the Western world. It is unclear if this is related to the ubiquitous use of traditional medicine in Eastern healthcare, but the use of complementary and alternative medicine (CAM) modalities in countries like Korea may be as high as 76%. Among patients with PD, herbal medicines, health supplement foods, and acupuncture are interventions which are increasingly used throughout the world. Countries like Korea, China, India, and Japan have long embraced and incorporated traditional medicine into modern management of conditions such as PD, but research into various CAM modalities remains in its infancy limiting evidence-based recommendations for many treatments. We reviewed the literature on CAM treatments for PD, focusing on mind-body interventions and natural products. Based on evidence limited to randomized-controlled trials we found that mind-body interventions are generally effective forms of physical activity that are likely to foster good adherence and may reduce disability associated with PD. Based on the current data, modalities like Tai Chi and dance are safe and beneficial in PD, but better studies are needed to assess the effects of other frequently used modalities such as yoga and acupuncture. Furthermore, despite centuries of experience using medicinal herbs and plants in Eastern countries, and despite substantial preclinical data on the beneficial effects of nutritional antioxidants as neuroprotective agents in PD, there is insufficient clinical evidence that any vitamin, food additive, or supplement, can improve motor function or delay disease progression in PD.
    10/2014; 7(2):57-66. DOI:10.14802/jmd.14009
  • Source
    Complementary Therapies in Medicine 02/2015; DOI:10.1016/j.ctim.2015.01.015 · 2.22 Impact Factor